Log in

Relevant bibliographies by topics / And cutaneous mucormycosis / Journal articles

To see the other types of publications on this topic, follow the link: And cutaneous mucormycosis.

Journal articles on the topic 'And cutaneous mucormycosis'

Author: Grafiati

Published: 7 June 2025

Last updated: 16 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'And cutaneous mucormycosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Jindal, Jyoti, and Vikas Garg. "Cutaneous mucormycosis: Unveiling rare manifestations." Journal of Family Medicine and Primary Care 14, no. 6 (2025): 2561–64. https://doi.org/10.4103/jfmpc.jfmpc_1603_24.

Full text

Abstract:

ABSTRACT Mucormycosis is a rare but life-threatening fungal infection caused by Mucorales, with high morbidity and mortality rates, especially among immunocompromised individuals. We report six cases of rare manifestations of cutaneous mucormycosis. To describe rare manifestations of cutaneous mucormycosis, highlighting the importance of prompt recognition and treatment to improve patient outcomes. Retrospective review of medical records from 2021 to 2023. This case series presents six patients with rare manifestations of cutaneous mucormycosis. The patients’ ages ranged from 25 to 60 years, w

APA, Harvard, Vancouver, ISO, and other styles

2

Castrejón-Pérez, Ana Daniela, Esperanza C. Welsh, Ivett Miranda, Jorge Ocampo-Candiani, and Oliverio Welsh. "Cutaneous mucormycosis." Anais Brasileiros de Dermatologia 92, no. 3 (2017): 304–11. http://dx.doi.org/10.1590/abd1806-4841.20176614.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Karyadi, Erlinda, and Leoni Agnes. "Cutaneous Mucormycosis." Cermin Dunia Kedokteran 49, no. 2 (2022): 68. http://dx.doi.org/10.55175/cdk.v49i2.1726.

Full text

Abstract:

<p>Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi from phylum Glomeromycota. This disease is frequently found in poorly controlled diabetic patients and immunosuppressed individuals. It is usually acquired by direct inoculation through trauma.<br />The clinical presentation is nonspecific indurated plaque rapidly evolves to necrosis. Diagnosis should be confirmed by demonstration of the etiological agent and molecular tests. First-line therapy is amphotericin B combined with surgery; second line treatment include posaconazole<br />and isa

APA, Harvard, Vancouver, ISO, and other styles

4

Karyadi, Erlinda, and Leoni Agnes. "Cutaneous Mucormycosis." Cermin Dunia Kedokteran 49, no. 2 (2022): 69. http://dx.doi.org/10.55175/cdk.v49i2.1740.

Full text

Abstract:

<p>Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi from phylum Glomeromycota. This disease is frequently found in poorly controlled diabetic patients and immunosuppressed individuals. It is usually acquired by direct inoculation through trauma.<br />The clinical presentation is nonspecific indurated plaque rapidly evolves to necrosis. Diagnosis should be confirmed by demonstration of the etiological agent and molecular tests. First-line therapy is amphotericin B combined with surgery; second line treatment include posaconazole<br />and isa

APA, Harvard, Vancouver, ISO, and other styles

5

Mizutari, Kumiko, Katsutaro Nishimoto, and Tomomichi Ono. "Cutaneous Mucormycosis." Journal of Dermatology 26, no. 3 (1999): 174–77. http://dx.doi.org/10.1111/j.1346-8138.1999.tb03450.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Umbert, Ignacio J., and W. P. Daniel Su. "Cutaneous mucormycosis." Journal of the American Academy of Dermatology 21, no. 6 (1989): 1232–34. http://dx.doi.org/10.1016/s0190-9622(89)70336-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vulsteke, Jean‐Baptiste, and Dries Deeren. "Cutaneous mucormycosis." Transplant Infectious Disease 21, no. 2 (2019): e13039. http://dx.doi.org/10.1111/tid.13039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Flagothier, C., J. E. Arrese, P. Quatresooz, and G. E. Piérard. "Cutaneous mucormycosis." Journal de Mycologie Médicale 16, no. 2 (2006): 77–81. http://dx.doi.org/10.1016/j.mycmed.2006.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Chang, Hung, Po-Nan Wang, and Yenlin Huang. "Cutaneous mucormycosis." Infection 46, no. 6 (2018): 901–2. http://dx.doi.org/10.1007/s15010-018-1179-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Karyadi, Erlinda, and Leoni Agnes. "Cutaneous Mucormycosis." Cermin Dunia Kedokteran 49, no. 2 (2022): 69–72. http://dx.doi.org/10.55175/cdk.v49i2.193.

Full text

Abstract:

Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi from phylum Glomeromycota. This disease is frequently found in poorly controlled diabetic patients and immunosuppressed individuals. It is usually acquired by direct inoculation through trauma. The clinical presentation is nonspecific indurated plaque rapidly evolves to necrosis. Diagnosis should be confirmed by demonstration of the etiological agent and molecular tests. First-line therapy is amphotericin B combined with surgery; second line treatment include posaconazole and isavuconazole. Cutaneous muc

APA, Harvard, Vancouver, ISO, and other styles

11

Marie, Nizigiyimana Jean, Yacoub Mkheittirate, Niyomwungere Elias, et al. "Acute Invasive Fungal Facial Cellulitis Associated to Actimycosis in a Diabetic Patient: A Case Presentation." Scholars Journal of Medical Case Reports 13, no. 01 (2025): 23–27. https://doi.org/10.36347/sjmcr.2025.v13i01.003.

Full text

Abstract:

Background: Acute invasive fungal cellulitis is a potentially leathal infection due to opportunistic fungi of the order Mucorales, mainly affecting immunocompromised individuals. Due to its non-specific symptomatology, dominated mostly by tissue necrosis, diagnosis is often delayed, adversely affecting prognosis. This infection predominantly arises in the nose and paranasal sinuses. Mucormycosis affecting sollely the cheek region are uncommon. We believe this ist he first case of a localized mucormycosis of the cheek. Moreover, Actinomycoses and mucormycoses occur most often in patients with i

APA, Harvard, Vancouver, ISO, and other styles

12

Luthra, Meera, Himaanee Mirakhur, and Virender Sekhon. "Neonatal cutaneous mucormycosis." Journal of Clinical Neonatology 5, no. 4 (2016): 262. http://dx.doi.org/10.4103/2249-4847.194166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Carpenter, Christopher F., and Aruna K. Subramanian. "Cutaneous Zygomycosis (Mucormycosis)." New England Journal of Medicine 341, no. 25 (1999): 1891. http://dx.doi.org/10.1056/nejm199912163412504.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

BENITO, A., P. CORNEJO, F. LOPEZ-RIOS, C. GONZALEZ-LOIS, and J. L. RODRIGUEZ-PERALTO. "PRIMARY CUTANEOUS MUCORMYCOSIS." American Journal of Dermatopathology 20, no. 6 (1998): 594. http://dx.doi.org/10.1097/00000372-199812000-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Akritidis, Nikolaos, Demetrios Papaioannides, Panagiotis Korantzopoulos, and Evangelia Kitsiou. "Necrotizing cutaneous mucormycosis." Hospital Medicine 63, no. 5 (2002): 308–9. http://dx.doi.org/10.12968/hosp.2002.63.5.2028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Hicks, Wesley L., Ken Nowels, and John Troxel. "Primary cutaneous mucormycosis." American Journal of Otolaryngology 16, no. 4 (1995): 265–68. http://dx.doi.org/10.1016/0196-0709(95)90155-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Coerdt, Kathleen M., Elizabeth G. Zolper, Amy G. Starr, Kenneth L. Fan, Christopher E. Attinger, and Karen K. Evans. "Cutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients." Archives of Plastic Surgery 48, no. 2 (2021): 231–36. http://dx.doi.org/10.5999/aps.2020.00549.

Full text

Abstract:

Mucormycosis is an invasive, rapidly progressive, life-threatening fungal infection, with a propensity for diabetic, immunosuppressed, and trauma patients. The classic rhinocerebral variation is most common in diabetic patients. While the cutaneous form is usually caused by direct inoculation in immunocompetent patients. Cutaneous mucormycosis manifests in soft tissue and risks involvement of underlying structures. Tibial osteomyelitis can also occur secondary to cutaneous mucormycosis but is rare. Limb salvage is typically successful after lower extremity cutaneous mucormycosis even when the

APA, Harvard, Vancouver, ISO, and other styles

18

Jagan, K., S. L. Shafy Ali Khan, and A. Mohamad Safwan. "Life-saving and Limb-saving in Case of Primary Cutaneous Mucormycosis of the Lower Limb." Kerala Surgical Journal 31, no. 1 (2025): 33–35. https://doi.org/10.4103/ksj.ksj_3_25.

Full text

Abstract:

Mucormycosis is a rare but potentially lethal fungal infection that can affect any organ system, especially in immune-compromised individuals. Cutaneous manifestations comprise < 10% of cases of mucormycosis. The hallmark of mucormycosis is angioinvasion followed by thrombosis and necrosis of infected tissues. Here, we report a case of primary invasive cutaneous mucormycosis in a 52-year-old male with uncontrolled diabetes who presented with necrotising fasciitis of the right leg. Ulcer edge biopsy and special stain examination were consistent with invasive cutaneous mucormycosis. Timely an

APA, Harvard, Vancouver, ISO, and other styles

19

Abhirami, B., Prabhat Kumar, Dharmendra Kumar Mishra, and Satyendra Prasad Yadav. "Secondary Cutaneous Mucormycosis Post-COVID-19." Indian Journal of Dermatology 67, no. 2 (2022): 206. http://dx.doi.org/10.4103/ijd.ijd_781_21.

Full text

Abstract:

Background: Mucormycosis is an angioinvasive mucorales fungal infection. Cutaneous type formed 10.5% of cases in India in precovid-19 era. Glucocorticoid-induced immunosuppression and hyperglycemia, reusable oxygen humidifiers in COVID-19 therapy, and preexisting uncontrolled diabetes mellitus contribute to post-COVID-19 mucormycosis. However, for post-COVID-19 cutaneous mucormycosis, sufficient data is not available. Aim: To study factors related to post-COVID-19 cutaneous mucormycosis. Methodology: Clinical and investigation details of six patients admitted in tertiary center with post-COVID

APA, Harvard, Vancouver, ISO, and other styles

20

Chang, Nicholas, James McKee, Valerie Marmolejo, and Arnold Cua. "Primary Cutaneous Mucormycosis of the Lower Extremity in a Male Patient With Diabetes." Wounds: a compendium of clinical research and practice 35, no. 3 (2023): e98-e101. http://dx.doi.org/10.25270/wnds/22045.

Full text

Abstract:

Introduction. Mucormycosis is a rare but serious angioinvasive fungal infection that can affect the cutaneous system. Primary cutaneous mucormycosis is caused by direct inoculation and is most prevalent in immunocompromised hosts, particularly those with diabetes. A high index of suspicion is necessary for this condition in patients with rapid and deep extension of necrosis despite aggressive surgical intervention. Deep tissue specimens should be sent for fungal culture and histologic analysis for confirmation of the diagnosis. Early and aggressive debridement to prevent spread to deeper tissu

APA, Harvard, Vancouver, ISO, and other styles

21

White, Mark. "978. Disease Associations and Outcomes in Hospitalized Patients with Non-Cutaneous Mucormycosis: Data from the National Inpatient Sample." Open Forum Infectious Diseases 8, Supplement_1 (2021): S580. http://dx.doi.org/10.1093/ofid/ofab466.1172.

Full text

Abstract:

Abstract Background Data regarding comorbidities and hospital outcomes among patients with non-cutaneous mucormycosis is primarily derived from case reports and single institution series. This study was undertaken to define the prevalence of this condition among adult inpatients in the United States and to measure the frequency of comorbid illnesses and outcomes of inpatients with mucormycosis. Methods The 2016 National Inpatient Sample was used to identify a cohort of patients with a hospital diagnosis of non-cutaneous mucormycosis. Patients with mucormycosis and comorbid medical illnesses we

APA, Harvard, Vancouver, ISO, and other styles

22

Hoesly, Paul M., Stephen Pool, and Fridolin J. Hoesly. "Post-traumatic cutaneous mucormycosis." IDCases 24 (2021): e01132. http://dx.doi.org/10.1016/j.idcr.2021.e01132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Al-Tarrah, Khaled, Mahmoud Abdelaty, Ahmad Behbahani, Eman Mokaddas, Helmy Soliman, and Ahdi Albader. "Cutaneous mucormycosis postcosmetic surgery." Medicine 95, no. 27 (2016): e4185. http://dx.doi.org/10.1097/md.0000000000004185.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bhattacharya, Sankha, and Aseem Setia. "Mucormycosis and its implication in COVID-19." Indian Journal of Pharmacy and Pharmacology 8, no. 2 (2021): 97–99. http://dx.doi.org/10.18231/j.ijpp.2021.016.

Full text

Abstract:

Mucormycosis is a life-threatening fungal infection caused by a group of moulds known as mucormycetes. It is a viral disease, increasingly progressive, rapidly triggers in diabetic, immunocompromised and trauma patients. Diabetic patients seem to have the classic rhinocerebral variant. Rhinocerebral mucormycosis begins as a nasal cavity, paranasal sinus, and orbital soft tissue infection. In immunocompetent patients, direct injection also induces cutaneous form. Cutaneous mucormycosis occurs in soft tissue and may infect underlying tissues. Mucormycosis is more frequent in people with major un

APA, Harvard, Vancouver, ISO, and other styles

25

Kuy, SreyRam, Chun He, and David C. Cronin. "Renal Mucormycosis: A Rare and Potentially Lethal Complication of Kidney Transplantation." Case Reports in Transplantation 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/915423.

Full text

Abstract:

Renal mucormycosis is a rare and potentially lethal complication of kidney transplantation. We describe two cases of renal mucormycosis following deceased donor kidney transplantation. This is the second report of renal mucormycosis following kidney transplantation in the United States, and the first case of renal mucormycosis infection presumed to be of recipient origin. Case A had an early presentation of mucormycosis isolated to the kidney allograft. He had an unexpected rise in serum creatinine and leukocytosis necessitating allograft biopsy which showed mucormycosis. He underwent transpla

APA, Harvard, Vancouver, ISO, and other styles

26

Kavishangari, J., and P. Jeepara. "A Case of Primary Cutaneous Mucormycosis in a Type II Diabetes Mellitus Patient." Batticaloa Medical Journal 18, no. 1 (2024): 35–36. http://dx.doi.org/10.4038/bmj.v18i1.32.

Full text

Abstract:

Mucormycosis is a rapidly progressive, angioinvasive, often fatal fungal infection caused by a ubiquitous filamentous fungus belonging to the order Mucorales, giving rise to rhinocerebral, pulmonary, cutaneous, gastrointestinal, disseminated and other rare clinical manifestations, especially in immune-compromised individuals. Cutaneous manifestation is uncommon and rarely reported in Sri Lanka. Treatment involves medical management combined with surgical interventions. Here we report a case of a patient who had cutaneous mucormycosis involving the left lower limb following trauma, leading to a

APA, Harvard, Vancouver, ISO, and other styles

27

Nair, Kharishma P., Siddartha Gowthaman S., Meghana S. Bagalgotkar, Vinoth S., and Ramanathan Manickam. "Post traumatic cutaneous mucormycosis: a diagnostic dilemma." International Surgery Journal 8, no. 5 (2021): 1610. http://dx.doi.org/10.18203/2349-2902.isj20211840.

Full text

Abstract:

The incidence of mucormycosis, an invasive fungal disease, is more in the developing countries, especially among the immunocompromised individuals. However, this disease can also occur in those without any predisposing factors. In the developed countries, those undergoing haematopoetic stem cell transplantation were more prone to developing this disease. There can be varied presentations of mucormycosis. It could be rhinocerebral, pulmonary, cutaneous, gastrointestinal or even disseminated forms. Post traumatic mucormycosis is infrequently reported and is often difficult to diagnose earlier du

APA, Harvard, Vancouver, ISO, and other styles

28

Foster, Catherine, Paula Revell, Judith R. Campbell, and Lucila Marquez. "2465. Healthcare-Associated Pediatric Cutaneous Mucormycosis at Texas Children’s Hospital, 2012–2019." Open Forum Infectious Diseases 6, Supplement_2 (2019): S853—S854. http://dx.doi.org/10.1093/ofid/ofz360.2143.

Full text

Abstract:

Abstract Background Cutaneous mucormycosis in children is a rare fungal infection which primarily occurs in patients with underlying medical conditions and is associated with significant morbidity. We describe characteristics of pediatric patients with healthcare-associated (HCA) cutaneous mucormycosis at Texas Children’s Hospital (TCH) and results of an outbreak investigation. Methods Patients at TCH were identified retrospectively through review of the TCH Microbiology Laboratory mycology culture reports from 1/1/2012–2/18/2019. Pediatric patients <21 years of age with cutaneous mucormyco

APA, Harvard, Vancouver, ISO, and other styles

29

Garrido, Pedro Miguel, Rita Pimenta, Isabel Viana, Heinz Kutzner, Paulo Filipe, and Luís Soares‐Almeida. "Cutaneous mucormycosis mimicking pancreatic panniculitis." Journal of Cutaneous Pathology 48, no. 8 (2021): 1007–9. http://dx.doi.org/10.1111/cup.13763.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Herrero, EH, M. Sánchez, A. Agrifoglio, et al. "Cutaneous mucormycosis in the ICU." Critical Care 19, Suppl 1 (2015): P88. http://dx.doi.org/10.1186/cc14168.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

TOURAUD, J. "Disseminated cutaneous mucormycosis during AIDS." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S195. http://dx.doi.org/10.1016/s0926-9959(98)95284-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Lewis, Russell E. "Cutaneous Mucormycosis in Tornado Survivors." Current Fungal Infection Reports 5, no. 4 (2011): 187–89. http://dx.doi.org/10.1007/s12281-011-0068-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Butt, Muhammad Umair, Muhammad Almas Murad, and Muhammad Afzal. "A case of Fungal Carbuncle in an Immune competent person." Pakistan Journal of Medical and Health Sciences 16, no. 5 (2022): 208–9. http://dx.doi.org/10.53350/pjmhs22165208.

Full text

Abstract:

Mucormycosis is vessel invading fungal infection and have a very poor prognosis around the globe. It is mostly seen in immunocompromised people but a rare finding can occur in normal people also, however a deep seated cutaneous infection is rare in surgery domain.Multiple types of Mucormycosis have been reported in literature with the cutaneous manifestation being the least common, tissue diagnosis by biopsy followed by antifungals and surgical debridement’s lead to the only treatment modalities available.A carbuncle which basically is a contiguous hair follicle infection that discharges pus f

APA, Harvard, Vancouver, ISO, and other styles

34

Sharma, Sahil, Bhavesh Kumar, Shivangi Manglik, Harneet Kaur Narula, Imran Ali, and Shreyas Mishra. "Rhino-orbital mucormycosis with cutaneous involvement in an HBV-positive patient: a case report and review of the literature." International Journal of Otorhinolaryngology and Head and Neck Surgery 11, no. 3 (2025): 299–304. https://doi.org/10.18203/issn.2454-5929.ijohns20251518.

Full text

Abstract:

Mucormycosis is a rare fungal angioinvasive disease characterized by infarction and tissue necrosis. It is an opportunistic infection mainly affecting patients with impaired immunity, as seen in patients with diabetes mellitus with or without ketoacidosis, injudicious use of steroid therapy, hematological malignancy, bone marrow transplant, chemotherapy, neutropenia, as well with deferoxamine therapy. The various clinical variants of mucormycosis include rhino-orbitocerebral, pulmonary, cutaneous, and disseminated forms, among which the rhino-orbital-cerebral type is the most common. A notable

APA, Harvard, Vancouver, ISO, and other styles

35

Ezzy, Mustafa K., Pushkaraj A. Kulkarni, Shivali K. Patekar, Kshitij D. Shah, and Renuka A. Bradoo. "Rhino-orbito-cerebral with cutaneous mucormycosis." International Journal of Otorhinolaryngology and Head and Neck Surgery 8, no. 8 (2022): 685. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20221888.

Full text

Abstract:

<p>"Mucormycosis" term is used for a group of fungal diseases caused by the order mucorales. It typically presents as sino-nasal-orbital involvement and rarely involves skin. Management of such cases is quite challenging. Reported here is a case of a young girl, who presented with right eye swelling and reduced vision and got detected with type 1 diabetes mellitus on admission with rare occurrence of cutaneous lesions while on treatment. Direct nasal endoscopy with biopsy was undertaken. KOH and histopathology report was suggestive of mucormycosis, for which the patient was administered

APA, Harvard, Vancouver, ISO, and other styles

36

Ahmadinejad, Zahra, Hamideh Khazraiyan, Fahime Ghanbari, Bahram Ahmadi, and Mohsen Gerami Shoar. "Cutaneous Mucormycosis in a Diabetic Patient following Traditional Dressing." Case Reports in Dermatological Medicine 2013 (2013): 1–3. http://dx.doi.org/10.1155/2013/894927.

Full text

Abstract:

Cutaneous mucormycosis is a rare manifestation of an aggressive fungal infection. Early diagnosis and treatment are vitally important in improving outcome. We report an unusual case presenting with progressive necrotizing fasciitis due to mucormycosis following trauma and dressing by man-made herbal agents.

APA, Harvard, Vancouver, ISO, and other styles

37

Raju, Feba V., Saramma Mathew Fenn, Karthik Rajaram Mohan, and Ravi Kumar. "Review on mucormycosis – A gloom epoch." Journal of Academy of Dental Education 8 (January 2, 2023): 37–41. http://dx.doi.org/10.25259/jade_19_2022.

Full text

Abstract:

Mucormycosis recently known with the term as black fungus belongs to the Zygomycetes family. It is a filamentous non-septate fungus. Mucormycosis is not a novel disease, although it is becoming more well-known as a result of the extensive transmission of COVID-19-associated mucormycosis. COVID-19 is currently undergoing a catastrophic phase, which is being exacerbated by the devastating spread of mucormycosis. Mucormycosis identifies the target site by exploiting conditions such as immunocompromised health, steroid therapy, and diabetes that predispose patients to infection. Mucormycosis is mo

APA, Harvard, Vancouver, ISO, and other styles

38

Almarhabi, Hassan, Esam Alasmari, Faysal Farahat, et al. "977. Invasive Mucormycosis in a Tertiary Care Hospital, Western Saudi Arabia: 11-Year Retrospective Chart Review, from 2009 – 2019." Open Forum Infectious Diseases 8, Supplement_1 (2021): S579—S580. http://dx.doi.org/10.1093/ofid/ofab466.1171.

Full text

Abstract:

Abstract Background Mucormycosis is a rare, life-threatening invasive fungal disease that mostly affects immunocompromised hosts. the objectives of this study to assess clinical presentations and outcomes among patients with mucormycosis in a tertiary care hospital, western Saudi Arabia. Methods A retrospective chart review of cases diagnosed with mucormycosis was conducted from January 2009 to December 2019 in King Abdulaziz Medical City, Jeddah, in the western region of Saudi Arabia. Data were obtained on demographic information, comorbidities including immunocompromised conditions Results 1

APA, Harvard, Vancouver, ISO, and other styles

39

Skiada, Anna, Maria Drogari-Apiranthitou, Ioannis Pavleas, Eirini Daikou, and George Petrikkos. "Global Cutaneous Mucormycosis: A Systematic Review." Journal of Fungi 8, no. 2 (2022): 194. http://dx.doi.org/10.3390/jof8020194.

Full text

Abstract:

Cutaneous mucormycosis is the third most common clinical type of mucormycosis. The signs and symptoms vary widely, and it is important to make the diagnosis as early as possible in order to achieve a better outcome. We present a systematic review of its epidemiology, clinical presentation, diagnosis, and treatment, analyzing cases published from 1958 until 2021. The review was conducted according to the PRISMA guidelines and included 693 cases from 485 articles from 46 countries. Most publications were from North America (256 cases, 36.9%) and Asia (216 cases, 31.2%). The most common risk fact

APA, Harvard, Vancouver, ISO, and other styles

40

Reid, Gail, Joseph P. Lynch, Michael C. Fishbein, and Nina M. Clark. "Mucormycosis." Seminars in Respiratory and Critical Care Medicine 41, no. 01 (2020): 099–114. http://dx.doi.org/10.1055/s-0039-3401992.

Full text

Abstract:

AbstractMucormycosis is an infection caused by a group of filamentous molds within the order Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores into the nares or lungs, or inoculation into disrupted skin or wounds. In developed countries, mucormycosis occurs primarily in severely immunocompromised hosts (e.g., those with hematological malignancies, organ transplantation, neutropenia, autoimmune disorders, or other impairments in immunity). Only 6 to 10% of cases occur in subjects with no underlying disease. In contrast, in developing countries, most case

APA, Harvard, Vancouver, ISO, and other styles

41

Sayan, Muhammet, Huseyin Arpag, Mahmut Tokur, and Abdulkadir Yasir Bahar. "Pulmonary mucormycosis mimicking an endobronchial mass." Asian Cardiovascular and Thoracic Annals 26, no. 3 (2018): 242–44. http://dx.doi.org/10.1177/0218492318760711.

Full text

Abstract:

Mucormycosis is an opportunistic fungal infection that can infect different regions of the body. This entity may present in rhinocerebral, pulmonary, cutaneous, and disseminated forms. Although pulmonary mucormycosis is usually seen as an invasive parenchymal consolidation or cavitation, it may rarely present as an endobronchial mass. We describe a case of endobronchial mucormycosis in which the fungal mass was completely removed via rigid bronchoscopy before medical therapy.

APA, Harvard, Vancouver, ISO, and other styles

42

De Paepe, A., K. Dams, D. Robert, et al. "Two Cases of Post-Traumatic Mucormycosis due to Mucor circinelloides: Salvage Therapy with a Combination of Adjunctive Therapies." Case Reports in Infectious Diseases 2022 (May 4, 2022): 1–8. http://dx.doi.org/10.1155/2022/4949426.

Full text

Abstract:

Mucormycosis is a rare, emerging angioinvasive infection caused by ubiquitous filamentous fungi. In recent decades, an increase in cutaneous or post-traumatic mucormycosis has been reported. We describe two cases of post-traumatic wound infections with Mucor circinelloides, a mucor species only rarely reported as a cause of post-traumatic mucormycosis. Often considered lethal, management required a combination of medical and surgical therapies to achieve a favorable outcome in both cases.

APA, Harvard, Vancouver, ISO, and other styles

43

Ghaemi, Nosrat, Sepide Bagheri, and Sara Shirdelzade. "Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1." Journal of Pediatric Endocrinology and Metabolism 34, no. 7 (2021): 941–45. http://dx.doi.org/10.1515/jpem-2020-0623.

Full text

Abstract:

Abstract Objectives Mucormycosis is a life-threatening condition that can be present in diabetes mellitus. Although the rhino-orbito-cerebral form is the most common, other types may be developed as well. Case presentation The present study reports two children with diabetes who had the cutaneous and pulmonary forms of mucormycosis. The first case was a four-year-old boy without a history of diabetes admitted due to loss of consciousness and a necrotic lesion on his hand. The second was an 11-year-old boy with dyspnea, polyuria, and polydipsia who had developed diabetes two years before, and w

APA, Harvard, Vancouver, ISO, and other styles

44

Shinde, Snehal Girish, Assist Prof Babasaheb L. Chopade, and Dr Megha Salve. "Mucormycosis: A Review." International Journal of Pharmaceutical Research and Applications 09, no. 06 (2024): 167–73. https://doi.org/10.35629/4494-0906167173.

Full text

Abstract:

Mucormycosis is an angio invasive contamination that happens because of the fungi mucorales. It is an extraordinary sickness however more and more more identified in immunocompromised patients. It may be labeled into rhino-orbitocerebral, cutaneous, disseminated, gastrointestinal, and pulmonary types. Overall elevated mortality fee is reported, despite the fact that the competitive remedy is given. The predominant intention and cause of this evaluation associated with assessment and Etiopathogenesis of Mucormycosis, fatality of rhinocerebral Mucormycosis, latest advances in diagnostic and reme

APA, Harvard, Vancouver, ISO, and other styles

45

Zachary, Dalila, Kimberly Chapin, Linda Binns, and Karen Tashima. "Cutaneous Mucormycosis Complicating a Polymicrobial Wound Infection Following a Dog Bite." Case Reports in Infectious Diseases 2011 (2011): 1–3. http://dx.doi.org/10.1155/2011/348046.

Full text

Abstract:

We report a case of cutaneous mucormycosis andEnterobacterinfection developing in a 50-year-old diabetic woman following a dog bite that showed delayed development and diagnosis in comparison with typical zygomycotic cutaneous lesions.

APA, Harvard, Vancouver, ISO, and other styles

46

Srivani, Dr S., Dr S. Fernandez Vinola, and Dr Abinizha Dr. Abinizha. "Mucormycosis of Forearm Masquerading as Soft Tissue Sarcoma." Scholars Journal of Medical Case Reports 10, no. 10 (2022): 1066–68. http://dx.doi.org/10.36347/sjmcr.2022.v10i10.020.

Full text

Abstract:

Mucormycosis is a rare invasive and life-threatening fungal infection usually affecting immunocompromised individuals caused by zygomycetes fungi. Incidence of mucormycosis in immunocompetent individuals is quite rare and is usually attributed to minor trauma. Most common clinical presentations include rhinocerebral and pulmonary forms followed by cutaneous form of mucormycosis where it usually presents as indurated erythematous plaques, targetoid and purpuric lesions. We present a case of mucormycosis in a 34-year-old immunocompetent male presenting with forearm masquerading as soft tissue sa

APA, Harvard, Vancouver, ISO, and other styles

47

Seo, Bommie Florence, Jeong Hwa Seo, and Gyeol Yoo. "Primary cutaneous mucormycosis of the scalp." Archives of Plastic Surgery 48, no. 5 (2021): 526–27. http://dx.doi.org/10.5999/aps.2020.01340.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Adam, R. D., G. Hunter, J. DiTomasso, and G. Comerci. "Mucormycosis: Emerging Prominence of Cutaneous Infections." Clinical Infectious Diseases 19, no. 1 (1994): 67–76. http://dx.doi.org/10.1093/clinids/19.1.67.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Hurle, A., M. Isolina Campos-Herrero, H. Rodriguez, et al. "Cutaneous Mucormycosis of the Thoracic Wall." Clinical Infectious Diseases 22, no. 2 (1996): 373. http://dx.doi.org/10.1093/clinids/22.2.373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Chahal, Harinder S., Narine Abgaryan, Renuka Lakshminarayanan, and A. Tyrone Glover. "Orbital Mucormycosis Following Periorbital Cutaneous Infection." Ophthalmic Plastic and Reconstructive Surgery 33 (2017): S146—S148. http://dx.doi.org/10.1097/iop.0000000000000466.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!